The long-term prophylactic effect of salazosulphapyridine (Salazopyrin) in primarily resected patients with Crohn's disease. A controlled double-blind trial

Clinical Trial

A Wenckert et al. Scand J Gastroenterol. 1978.

. 1978;13(2):161-7.

doi: 10.3109/00365527809181743.

No abstract available

Cited by

Mesalamine for prophylaxis of small bowel Crohn's disease recurrence.
Bauer WM, Brzezinski A, Lashner BA. Bauer WM, et al. Curr Gastroenterol Rep. 1999 Oct;1(5):377-83. doi: 10.1007/s11894-999-0018-2. Curr Gastroenterol Rep. 1999. PMID: 10980975 Review.
Pharmacological and biochemical actions of sulphasalazine.
Hoult JR. Hoult JR. Drugs. 1986;32 Suppl 1:18-26. doi: 10.2165/00003495-198600321-00005. Drugs. 1986. PMID: 2877850 Review.
Postoperative outcome of Crohn's disease in 30 children.
Besnard M, Jaby O, Mougenot JF, Ferkdadji L, Debrun A, Faure C, Delagausie P, Peuchmaur M, Aigrain Y, Navarro J, Cézard JP. Besnard M, et al. Gut. 1998 Nov;43(5):634-8. doi: 10.1136/gut.43.5.634. Gut. 1998. PMID: 9824343 Free PMC article.
[Radical operation and recurrence prevention with azulfidine in Crohn disease: a prospective multicenter study--initial results].
Ewe K, Malchow H, Herfarth C. Ewe K, et al. Langenbecks Arch Chir. 1984;364:427-30. doi: 10.1007/BF01823251. Langenbecks Arch Chir. 1984. PMID: 6150408 Clinical Trial. German.
Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.
Gjuladin-Hellon T, Gordon M, Iheozor-Ejiofor Z, Akobeng AK. Gjuladin-Hellon T, et al. Cochrane Database Syst Rev. 2019 Jun 20;6(6):CD008414. doi: 10.1002/14651858.CD008414.pub3. Cochrane Database Syst Rev. 2019. PMID: 31220875 Free PMC article.